Sarah R. Smith
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Rasch analysis of the self-reported PedsQL™ 4.0 Generic Core Scales by Australian children.
Journal: Health and quality of life outcomes
Published: June 01, 2025
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression.
Journal: Journal of medical economics
Published: March 25, 2024
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.
Journal: Applied health economics and health policy
Published: March 21, 2023
Patient and staff perceptions of short procedural sedation with propofol for joint and fracture reductions in the Emergency Department: A qualitative study.
Journal: International emergency nursing
Published: March 04, 2023
Building a transdisciplinary expert consensus on the cognitive drivers of performance under pressure: An international multi-panel Delphi study.
Journal: Frontiers in psychology
Published: August 12, 2022
Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures.
Journal: PharmacoEconomics
Published: February 14, 2022
Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis.
Journal: Future oncology (London, England)
Published: February 04, 2022
How accurate are the longer-term projections of overall survival for cancer immunotherapy for standard versus more flexible parametric extrapolation methods?
Journal: Journal of medical economics
Published: January 21, 2022
Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures.
Journal: PharmacoEconomics
Published: December 19, 2021
Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 09, 2021
How does social context influence appraisal and help-seeking for potential cancer symptoms in adults aged 50 and over? A qualitative interview study.
Journal: European journal of cancer care
Published: May 09, 2021
The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden.
Journal: PharmacoEconomics
Published: March 06, 2021
Last Updated: 09/26/2026